In its notice dated June 2, NBEMS said the exam, conducted for admission to MS, MD and PG diploma courses, has been postponed to arrange for additional test centres and infrastructure.
Initially, we will look to take a small batch of a few hundred students, with a plan to increase this to 5,000 students in the next five years, and eventually 10,000 by 2036.'
India's largest drug maker Sun Pharmaceutical on Thursday posted a decline of 19 per cent year-on-year (Y-o-Y) for its consolidated net profit for the fourth quarter of the financial year 2025 (Q4FY25) at Rs 2,149.8 crore. Meanwhile, its revenue from operations rose by 8 per cent at Rs 12,958.8 crore.
India currently performs around 6,00,000 to 7,00,000 laser-assisted in situ keratomileusis (Lasik) and refractive procedures a year, and the uptake is accelerating.
Several multinational medical device makers are focusing on deepening their presence in India by expanding their local manufacturing footprint and research capabilities, a move that can catapult India into a strategic hub for the medical technology (medtech) industry. Among those increasing their reach in the country are Siemens Healthineers and Philips, signalling a broader shift from India being only a sales destination to becoming a global production and innovation base.
'Indian private universities can provide world-class education at one fourth the cost, home comforts, and direct links to Indian and global industries.'
Indian auto component exporters may suffer a hit of 2,700 crore to 4,500 crore on their earnings after the imposition of steep US tariffs on key automotive parts, credit rating agency ICRA said in a note on Monday. The new 25 per cent tariff on engines, transmission, electrical components, and other auto parts may moderate the overall auto component industry's revenue growth to 6-8 per cent in 2025-26 (FY26), down from an earlier projection of 8-10 per cent.
With stricter policies dampening the US/UK dream, Germany, Ireland and New Zealand are emerges as new study abroad destinations for Indian students.
Real estate developers are hoping that the slew of tax concessions announced in Union Budget 2025, set to take effect this financial year, will spur demand for affordable and mid-segment housing, even as the broader housing market shows signs of fatigue.
Leading chains plan Rs 40K crore infra revival to close capacity gap over next 3-5 years
According to the Department of Pharmaceuticals' annual report for 2024-25, India imported medical devices worth $8.1 billion, while exports stood at $3.7 billion in the financial year 2023-24 (FY24)
Children below the age of 15 years account for about 10 to 12 per cent of India's overall TB burden.
After the post-pandemic slump in demand, unsold inventory in the affordable housing segment in the top seven cities dropped by 19 per cent in the first quarter of the 2025 calendar year (Q1CY25), according to a report by real estate consultancy firm Anarock.
77 per cent of all transactions in the January-March 2025 period took place digitally, indicating continued preference for online car purchases.
The USTR report, released just ahead of the US' April 2 deadline for implementing reciprocal tariffs, has also cited high tariffs and price caps, which have not increased in line with inflation, as key obstacles for US businesses.
In its draft policy released last month, the CBSE had proposed conducting Class 10 board exams twice in an academic year from 2026.
Capital value appreciation outpaced rental value growth in several key micro-markets between 2021 and 2024, with Noida Sector 150 in the National Capital Region (NCR) leading the pack with a 128 per cent rise in capital values compared to rental value growth of just 66 per cent, according to a report by property consulting firm Anarock.
From premium electric motorcycles to mass-market scooters, manufacturers are rapidly expanding their portfolios to capture a larger share of the booming market.
A large number of medical device-manufacturing units have been forced to move to Vietnam and Malaysia due to delays, inconsistent timelines, and a lack of transparency in licensing processes, according to the Parliamentary Standing Committee on Health and Family Welfare.
According to a parliamentary response by the Union health ministry in 2023, around 654,000 families in Delhi are eligible to enrol under the scheme.
© 2025 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances